The appointment of Jeremy Grant and the cooperation with Ire...
The appointment of Jeremy Grant and the cooperation with Irenic are seen as positive steps towards strengthening Theravance's position. Irenic supports Theravance's potential to successfully complete the Phase 3 trial of ampreloxetine and deliver enhanced value to shareholders.
Press Release: Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3162Followers
0Following
7910Visitors
Follow